Page last updated: 2024-08-26

fulvestrant and niacinamide

fulvestrant has been researched along with niacinamide in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Bracher, F; Dietschreit, JCB; Ghazy, E; Glas, C; Jung, M; Ochsenfeld, C; Sippl, W; Urban, L; Wössner, N	1
Brown, RE; Buryanek, J; Pfister, S; Rytting, ME; Vats, TS; Wolff, JE	1
Agard, DA; Duan, D; Elnatan, D; Logie, J; McLaughlin, CK; Shoichet, BK; Shoichet, MS; Torosyan, H	1

Trials

1 trial(s) available for fulvestrant and niacinamide

Article	Year
Preliminary experience with personalized and targeted therapy for pediatric brain tumors. Pediatric blood & cancer, 2012, Jul-15, Volume: 59, Issue:1 Topics: Adolescent; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Bevacizumab; Biomarkers, Tumor; Boronic Acids; Bortezomib; Brain Neoplasms; Child; Child, Preschool; Curcumin; Disease-Free Survival; Estradiol; Female; Follow-Up Studies; Fulvestrant; Humans; Infant; Male; Niacinamide; Phenylurea Compounds; Pyrazines; Pyridines; Sirolimus; Sorafenib; Survival Rate	2012

Article

Year

Preliminary experience with personalized and targeted therapy for pediatric brain tumors.

Pediatric blood & cancer, 2012, Jul-15, Volume: 59, Issue:1

Topics: Adolescent; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Bevacizumab; Biomarkers, Tumor; Boronic Acids; Bortezomib; Brain Neoplasms; Child; Child, Preschool; Curcumin; Disease-Free Survival; Estradiol; Female; Follow-Up Studies; Fulvestrant; Humans; Infant; Male; Niacinamide; Phenylurea Compounds; Pyrazines; Pyridines; Sirolimus; Sorafenib; Survival Rate

2012

Other Studies

2 other study(ies) available for fulvestrant and niacinamide

Article	Year
Identification of the subtype-selective Sirt5 inhibitor balsalazide through systematic SAR analysis and rationalization via theoretical investigations. European journal of medicinal chemistry, 2020, Nov-15, Volume: 206 Topics: Drug Design; Histone Deacetylase Inhibitors; Mesalamine; Molecular Docking Simulation; Phenylhydrazines; Protein Conformation; Salicylic Acid; Sirtuins; Structure-Activity Relationship	2020
Internal Structure and Preferential Protein Binding of Colloidal Aggregates. ACS chemical biology, 2017, 01-20, Volume: 12, Issue:1 Topics: Bacterial Proteins; beta-Lactamases; Colloids; Coloring Agents; Congo Red; DNA; Dynamic Light Scattering; Estradiol; Fluoresceins; Fulvestrant; Niacinamide; Peptides; Phenylurea Compounds; Protein Binding; Protein Folding; Proteins; Ribosomal Proteins; Scattering, Small Angle; Sorafenib; Trypsin; Trypsin Inhibitors; X-Ray Diffraction	2017

Article

Year

Identification of the subtype-selective Sirt5 inhibitor balsalazide through systematic SAR analysis and rationalization via theoretical investigations.

European journal of medicinal chemistry, 2020, Nov-15, Volume: 206

Topics: Drug Design; Histone Deacetylase Inhibitors; Mesalamine; Molecular Docking Simulation; Phenylhydrazines; Protein Conformation; Salicylic Acid; Sirtuins; Structure-Activity Relationship

2020

Internal Structure and Preferential Protein Binding of Colloidal Aggregates.

ACS chemical biology, 2017, 01-20, Volume: 12, Issue:1

Topics: Bacterial Proteins; beta-Lactamases; Colloids; Coloring Agents; Congo Red; DNA; Dynamic Light Scattering; Estradiol; Fluoresceins; Fulvestrant; Niacinamide; Peptides; Phenylurea Compounds; Protein Binding; Protein Folding; Proteins; Ribosomal Proteins; Scattering, Small Angle; Sorafenib; Trypsin; Trypsin Inhibitors; X-Ray Diffraction

2017